UBS Group AG - CUMBERLAND PHARMACEUTICALS I ownership

CUMBERLAND PHARMACEUTICALS I's ticker is CPIX and the CUSIP is 230770109. A total of 22 filers reported holding CUMBERLAND PHARMACEUTICALS I in Q3 2023. The put-call ratio across all filers is 0.20 and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of CUMBERLAND PHARMACEUTICALS I
ValueSharesWeighting
Q2 2023$12,666
+130.0%
8,616
+205.1%
0.00%
Q1 2023$5,507
-34.3%
2,824
-24.1%
0.00%
Q4 2022$8,377
+4.7%
3,723
-1.6%
0.00%
Q2 2022$8,000
-11.1%
3,783
+15.3%
0.00%
Q1 2022$9,000
+80.0%
3,280
+69.7%
0.00%
Q3 2021$5,000
+400.0%
1,933
+315.7%
0.00%
Q2 2021$1,000
-88.9%
465
-84.4%
0.00%
Q1 2021$9,000
+50.0%
2,979
+42.0%
0.00%
Q4 2020$6,000
-14.3%
2,098
-4.7%
0.00%
Q3 2020$7,000
-50.0%
2,201
-46.7%
0.00%
Q2 2020$14,000
+40.0%
4,133
+44.4%
0.00%
Q1 2020$10,000
+25.0%
2,862
+85.1%
0.00%
Q4 2019$8,000
+33.3%
1,546
+54.6%
0.00%
Q1 2019$6,000
-72.7%
1,000
-73.1%
0.00%
Q4 2018$22,000
-21.4%
3,711
-24.7%
0.00%
Q3 2018$28,000
+64.7%
4,926
+74.6%
0.00%
Q2 2018$17,000
+70.0%
2,822
+97.5%
0.00%
Q1 2018$10,000
-37.5%
1,429
-35.3%
0.00%
Q4 2017$16,000
+6.7%
2,210
+6.7%
0.00%
Q3 2017$15,000
-31.8%
2,071
-33.8%
0.00%
Q2 2017$22,000
+120.0%
3,130
+123.3%
0.00%
Q1 2017$10,000
+25.0%
1,402
-6.3%
0.00%
Q4 2016$8,000
-20.0%
1,496
-23.7%
0.00%
Q3 2016$10,000
+150.0%
1,961
+118.9%
0.00%
Q2 2016$4,000
+33.3%
896
+15.2%
0.00%
Q1 2016$3,0000.0%778
+41.5%
0.00%
Q4 2015$3,000
-72.7%
550
-70.4%
0.00%
Q3 2015$11,000
+83.3%
1,860
+89.0%
0.00%
Q4 2014$6,0009840.00%
Other shareholders
CUMBERLAND PHARMACEUTICALS I shareholders Q3 2023
NameSharesValueWeighting ↓
Sterling Financial Planning, Inc. 22,031$46,0000.03%
BERKSHIRE ASSET MANAGEMENT LLC/PA 189,048$392,0000.03%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 286,655$595,0000.01%
Renaissance Technologies 622,228$1,291,0000.00%
ACADIAN ASSET MANAGEMENT LLC 188,164$390,0000.00%
Oakworth Capital, Inc. 3,052$6,0000.00%
BlackRock Inc. 140,248$292,0000.00%
Citadel Advisors 32,300$67,0000.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 28,900$60,0000.00%
TWO SIGMA ADVISERS, LP 34,592$72,0000.00%
View complete list of CUMBERLAND PHARMACEUTICALS I shareholders